Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys - Hashimoto, Masayuki; Nagata, Noriyo; Homma, Tomoyuki; Maeda, Hiroki; Dohi, Keiji; Seki, Naomi M.; Yoshihara, Ken; Iwata-Yoshikawa, Naoko; Shiwa-Sudo, Nozomi; Sakai, Yusuke; Shirakura, Masayuki; Kishida, Noriko; et al. (Vaccine, 2022)
Keywords: adjuvants; Allergy and Immunology; Animals; Antibodies; Antibodies, Neutralizing; Antibodies, Viral; Antigens; Cell-mediated immunity; Chromatography; Clinical trials; Coronavirus disease 2019; Coronaviruses; COVID-19; COVID-19 - prevention & control; COVID-19 - therapy; COVID-19 Serotherapy; COVID-19 vaccines; Cynomolgus monkeys; Dosage; dose response; Enzymes; genomics; humans; Immune response (humoral); Immunization; Immunization, Passive; Immunogenicity; Immunogenicity, Vaccine; Laboratories; Lung diseases; Lymphocytes T; Macaca fascicularis; messenger RNA; Monkeys; Neutralizing; pandemic; Pandemics; Proteins; Pseudoviridae; Recombinant protein vaccine; S-268019-b; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Spike Glycoprotein, Coronavirus; Squalene; throat; Vaccine efficacy; Vaccines; Viral diseases; Viral Vaccines; Viruses; Weight loss; United States--US; Japan; Cynomolgus monkeys; Severe acute respiratory syndrome coronavirus 2; Coronavirus disease 2019; Recombinant protein vaccine; S-268019-b